Newish Biotech (wuxi) Co., Ltd.
Clinical trials sponsored by Newish Biotech (wuxi) Co., Ltd., explained in plain language.
-
Experimental biologic aims to eliminate persistent HPV16 infection
Disease control Recruiting nowThis study tests whether an experimental biologic called NWRD09 can clear persistent cervical HPV16 infection in women aged 45 to 65. Participants receive either NWRD09 or a placebo by injection, and researchers check if the virus is gone after 16 weeks. The trial also monitors f…
Phase: NA • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Experimental shot aims to clear stubborn HPV infection in the anal region
Disease control Recruiting nowThis early-stage trial tests an experimental therapy called NWRD09 in 10 adults aged 18 to 60 who have had a persistent HPV16 infection in the anal area for at least a year. The therapy is given as an injection and is designed to help the body clear the virus. The study primarily…
Phase: PHASE1 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New shot aims to reverse HPV-linked cervical damage
Disease control Recruiting nowThis study tests an experimental treatment called NWRD08 in 150 women with high-grade cervical lesions (CIN2/3) caused by HPV types 16 or 18. The treatment is given as a shot followed by a quick electrical pulse to help it enter cells. The goal is to see if it can shrink or elimi…
Phase: PHASE2 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC